Suraksha Diagnostic IPO Listing Date: All you need to know before debut on NSE, BSE

Suraksha Diagnostic IPO: Subscription

The IPO, with a price band fixed at ₹420-₹441 per share, received a total subscribed 1.27 times, receiving bids for 1.70 crore equity shares against 1.34 crore equity shares on offer.

Suraksha Diagnostic IPO: Objective

The ₹846 crore issue was an offer-for-sale by promoters and investor shareholders. There was no fresh issue component.

As it is solely an OFS, the firm will not receive any IPO proceeds. The funds raised will go to the selling shareholders.

Before the IPO, the company had collected ₹254 crore from anchor investors, including Troo Capital, Carnelian Bharat Amritkaal Fund, Integrated Core Strategies (Asia), Societe Generale, Tusk Investments, Aditya Birla Sunlife Mutual Fund (MF), Kotak MF, Bandhan MF, Mirae Asset MF, Quant MF and Nippon MF.

Suraksha Diagnostic IPO: Listing date and time

Suraksha Diagnostic shares will be listed on the NSE (National Stock Exchange) and the BSE (formerly Bombay Stock Exchange) on Friday, December 6 at 10 am.

Suraksha Diagnostic provides pathology and radiology services, as well as medical consultation services, through its extensive operational network, which includes a central reference laboratory, eight satellite laboratories, and 215 customer touchpoints across states like Assam, Bihar, Meghalaya, and West Bengal.

During the financial year 2023-24, the firm conducted around 5.98 million tests, serving roughly 1.14 million patients.

ICICI Securities Ltd, SBI Capital Markets Ltd, and Nuvama Wealth Management Ltd are the book-running lead managers of the issue. Kfin Technologies Ltd is the registrar.